Leonid Timashev
Stock Analyst at RBC Capital
(4.93)
# 181
Out of 4,707 analysts
502
Total ratings
64.5%
Success rate
27.4%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Downgraded: Hold | $23 → $19 | $15.00 | +26.71% | 32 | Sep 8, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $112 | $75.24 | +48.86% | 25 | Sep 1, 2026 | |
| AXSM Axsome Therapeutics | Rated: Buy | $297 | $207.70 | +42.99% | 40 | Sep 1, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $59 | $43.76 | +34.83% | 42 | Sep 1, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $273 → $299 | $240.02 | +24.57% | 15 | Aug 28, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $203 → $251 | $207.24 | +21.12% | 14 | Aug 26, 2026 | |
| INSM Insmed | Maintained: Buy | $195 | $124.75 | +56.32% | 26 | Aug 25, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $450 | $350.73 | +28.30% | 17 | Aug 25, 2026 | |
| CRMD CorMedix | Maintained: Buy | $13 → $14 | $8.17 | +71.36% | 16 | Aug 13, 2026 | |
| ADCT ADC Therapeutics | Maintained: Hold | $2 | $1.32 | +51.52% | 18 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $3.88 | +29.03% | 18 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $59 → $58 | $20.48 | +183.27% | 46 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.12 | +348.72% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $57.60 | -20.14% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $8.06 | +73.81% | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 → $20 | $6.64 | +201.43% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $449 → $462 | $352.79 | +30.96% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 → $79 | $73.47 | +7.53% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $20 | $25.31 | -20.98% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 → $21 | $14.05 | +49.52% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $50 | $25.63 | +95.08% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $38.85 | +23.55% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $15.24 | +31.23% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.20 | +19.05% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $45.47 | +23.16% | 22 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.70 | +328.57% | 7 | May 14, 2026 |
Biohaven
Sep 8, 2026
Downgraded: Hold
Price Target: $23 → $19
Current: $15.00
Upside: +26.71%
Cytokinetics
Sep 1, 2026
Maintained: Buy
Price Target: $112
Current: $75.24
Upside: +48.86%
Axsome Therapeutics
Sep 1, 2026
Rated: Buy
Price Target: $297
Current: $207.70
Upside: +42.99%
Edgewise Therapeutics
Sep 1, 2026
Maintained: Buy
Price Target: $59
Current: $43.76
Upside: +34.83%
Jazz Pharmaceuticals
Aug 28, 2026
Maintained: Buy
Price Target: $273 → $299
Current: $240.02
Upside: +24.57%
Revolution Medicines
Aug 26, 2026
Rated: Buy
Price Target: $203 → $251
Current: $207.24
Upside: +21.12%
Insmed
Aug 25, 2026
Maintained: Buy
Price Target: $195
Current: $124.75
Upside: +56.32%
BeOne Medicines AG
Aug 25, 2026
Maintained: Buy
Price Target: $450
Current: $350.73
Upside: +28.30%
CorMedix
Aug 13, 2026
Maintained: Buy
Price Target: $13 → $14
Current: $8.17
Upside: +71.36%
ADC Therapeutics
Aug 13, 2026
Maintained: Hold
Price Target: $2
Current: $1.32
Upside: +51.52%
Aug 13, 2026
Maintained: Buy
Price Target: $5
Current: $3.88
Upside: +29.03%
Aug 11, 2026
Rated: Buy
Price Target: $59 → $58
Current: $20.48
Upside: +183.27%
Aug 10, 2026
Maintained: Buy
Price Target: $14
Current: $3.12
Upside: +348.72%
Aug 6, 2026
Maintained: Hold
Price Target: $46
Current: $57.60
Upside: -20.14%
Aug 6, 2026
Maintained: Buy
Price Target: $14
Current: $8.06
Upside: +73.81%
Aug 6, 2026
Rated: Buy
Price Target: $19 → $20
Current: $6.64
Upside: +201.43%
Aug 6, 2026
Rated: Buy
Price Target: $449 → $462
Current: $352.79
Upside: +30.96%
Aug 6, 2026
Maintained: Buy
Price Target: $81 → $79
Current: $73.47
Upside: +7.53%
Aug 5, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $25.31
Upside: -20.98%
Aug 5, 2026
Rated: Buy
Price Target: $22 → $21
Current: $14.05
Upside: +49.52%
Aug 5, 2026
Maintained: Buy
Price Target: $51 → $50
Current: $25.63
Upside: +95.08%
Aug 4, 2026
Maintained: Buy
Price Target: $48
Current: $38.85
Upside: +23.55%
Aug 3, 2026
Maintained: Buy
Price Target: $20
Current: $15.24
Upside: +31.23%
Jul 30, 2026
Maintained: Hold
Price Target: $5
Current: $4.20
Upside: +19.05%
Jul 28, 2026
Maintained: Buy
Price Target: $56
Current: $45.47
Upside: +23.16%
May 14, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $0.70
Upside: +328.57%